Cc1ccc(Nc2nnc(SCC(O)=C(C#N)c3nc4ccccc4[nH]3)s2)c(C)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?